Protective effects of dietary phytoestrogens in chronic renal disease

Giovanetti, 1964, A low nitrogen diet with protein of high biological value for severe chronic uremia, Lancet, 1, 1000, 10.1016/S0140-6736(64)91919-1 Berlyne, 1965, Dietary treatment of chronic renal failure. Experience with a modified Giovanetti diet, Nephron, 2, 129, 10.1159/000179399 Kopple, 1973, Metabolic studies of low protein diets in uremia. I. Nitrogen and potassium, Medicine, 52, 583, 10.1097/00005792-197311000-00004 Barsotti, 1989, Effects of dietary therapy on urmeic symptoms and complications, 235 Mitch, 1996, Nutritional therapy of the uremic patient, 2382 Walser, 1999, Should protein intake be restricted in pre dialysis patients, Kidney Int, 55, 771, 10.1046/j.1523-1755.1999.055003771.x Brenner, 1982, Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis of aging, renal ablation, and intrinsic renal disease, N Engl J Med, 307, 652, 10.1056/NEJM198209093071104 Klahr, 1983, Role of dietary factors in the progression of chronic renal disease, Kidney Int, 24, 579, 10.1038/ki.1983.197 Rosman, 1984, Prospective randomized trial of early dietary protein restriction in chronic renal failure, Lancet, 2, 1291, 10.1016/S0140-6736(84)90818-3 Mitch, 1984, The effect of a ketoacid-amino acid supplement to a restricted diet on the progression of chronic renal failure, N Engl J Med, 311, 623, 10.1056/NEJM198409063111002 Ihle, 1989, The effect of protein restriction on the progression of renal insufficiency, N Engl J Med, 321, 1773, 10.1056/NEJM198912283212601 Walker, 1989, Restriction of dietary protein and progression of renal failure in diabetic nephropathy, Lancet, 2, 1411, 10.1016/S0140-6736(89)92032-1 Zeller, 1991, Low protein diets in renal disease, Diabetes Care, 14, 856, 10.2337/diacare.14.9.856 Fouque, 1992, Controlled low protein diets in chronic renal insufficiency: Meta-analysis, BMJ, 304, 216, 10.1136/bmj.304.6821.216 Pedrini, 1996, The effects of dietary protein restriction on the progression of diabetic and non-diabetic renal disease: A meta-analysis, Ann Intern Med, 124, 627, 10.7326/0003-4819-124-7-199604010-00002 Williams, 1987, Metabolic consequences of differing protein diets in experimental renal disease, Eur J Clin Invest, 17, 117, 10.1111/j.1365-2362.1987.tb02390.x Williams, 1987, Effect of varying quantity and quality of dietary protein intake in experimental renal disease in rats, Nephron, 46, 83, 10.1159/000184312 Barsotti, 1988, Effects of a vegetarian, supplemented diet on renal function, proteinuria, and glucose metabolism in patients with “overt” diabetic nephropathy and renal insufficiency, Contrib Nephrol, 65, 87, 10.1159/000415752 Jibani, 1991, Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: Effects on albumin excretion rate and nutritional status, Diabet Med, 8, 949, 10.1111/j.1464-5491.1991.tb01535.x Wardle, 1998, Soy protein diet therapy in renal disease, Nephron, 78, 328, 10.1159/000044944 Iwasaki, 1988, The influence of dietary protein source on longevity and age-related disease processes of Fischer rats, J Gerontol, 43, B5, 10.1093/geronj/43.1.B5 Shimokawa, 1993, Diet and the suitability of the male Fischer 343 rat as a model for aging research, J Gerontol, 48, B27, 10.1093/geronj/48.1.B27 Tomobe, 1998, Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease, Am J Kidney Dis, 31, 55, 10.1053/ajkd.1998.v31.pm9428452 Aukema, 1999, Dietary soy protein effects on inherited polycystic kidney disease are influenced by gender and protein level, J Am Soc Nephrol, 10, 300, 10.1681/ASN.V102300 Ogborn, 1998, Soy protein modification of rat polycystic kidney disease, Am J Physiol, 274, F541 Ogborn, 2000, Modification of polycystic kidney disease and fatty acid status by soy protein diet, Kidney Int, 57, 159, 10.1046/j.1523-1755.2000.00835.x D'Amico, 1992, Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome, Lancet, 339, 1131, 10.1016/0140-6736(92)90731-H Gentile, 1993, Treatment of proteinuric patients with a vegetarian soy diet and fish oil, Clin Nephrol, 40, 315 Soroka, 1998, Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients, Nephron, 79, 173, 10.1159/000045021 Anderson, 1998, Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes, Am J Clin Nutr, 68, 1347S, 10.1093/ajcn/68.6.1347S Hall, 1993, Abrogation of MRL/lpr lupus nephritis by dietary flaxseed, Am J Kidney Dis, 22, 326, 10.1016/S0272-6386(12)70326-8 Theofilopolous, 1985, Murine models of systemic lupus erythematosus, Adv Immunol, 37, 269, 10.1016/S0065-2776(08)60342-9 Ingram, 1995, Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model, Am J Kidney Dis, 25, 320, 10.1016/0272-6386(95)90015-2 Ogborn, 1999, Flaxseed ameliorates interstitial nephritis in rat polycystic kidney disease, Kidney Int, 55, 417, 10.1046/j.1523-1755.1999.00287.x Clark, 1995, Flaxseed: A potential treatment for lupus nephritis, Kidney Int, 48, 475, 10.1038/ki.1995.316 Martin, 1978, Phytoestrogen interaction with estrogen receptors in human breast cancer cells, Endocrinology, 103, 1860, 10.1210/endo-103-5-1860 Miksicek, 1994, Interaction of naturally occurring non-steroidal estrogens with expressed with recombinant human estrogen receptor, J Steroid Biochem Mol Biol, 49, 153, 10.1016/0960-0760(94)90005-1 Ros Barcelo, 1997, Lignification in plant cell walls, vol 176, 87 Axelson, 1984, Soya—A dietary source of the non-steroidal oestrogen equol in humans and animals, J Endocrinol, 102, 49, 10.1677/joe.0.1020049 Coward, 1993, Genistein and daidzein, and their β-glycoside conjugates: Anti-tumor isoflavones in soy bean foods from American and Asian diets, J Agric Food Chem, 41, 1961, 10.1021/jf00035a027 Wang, 1994, Isoflavone content in commercial soybean foods, J Agric Food Chem, 42, 1666, 10.1021/jf00044a016 Wang, 1994, Isoflavone composition of American and Japanese soybean in Iowa: Effects of variety, crop year, and location, J Agric Food Chem, 42, 1674, 10.1021/jf00044a017 Haytowitz, 1986, Legumes and Legume Products, 1 Young, 1991, Soy protein in relation to human protein and amino acid nutrition, J Am Diet Assoc, 91, 828, 10.1016/S0002-8223(21)01237-2 Thompson, 1991, Mammalian lignan production from various foods, Nutr Cancer, 16, 43, 10.1080/01635589109514139 Thompson, 1997, Variability in anticancer lignan levels in flaxseed, Nutr Cancer, 27, 26, 10.1080/01635589709514497 Mazur, 1996, Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples, Anal Biochem, 233, 169, 10.1006/abio.1996.0025 Slavin, 2000, Grain processing and nutrition, Crit Rev Food Sci Nutr, 40, 309, 10.1080/10408690091189176 Setchell, 1988, Mammalian lignans and phyto-estrogens. Recent studies on their formation, metabolism and biologic role in health and disease, 315 Borriello, 1985, Production and metabolism of lignans by the human faecal flora, J Appl Bacteriol, 58, 37, 10.1111/j.1365-2672.1985.tb01427.x Axelson, 1981, The excretion of lignans in rats: evidence for an intestinal bacterial source for this new group of compounds, FEBS Lett, 123, 337, 10.1016/0014-5793(81)80322-5 Rowland, 2000, Interindividual variation in metabolism of soy isoflavones and lignans: Influence of habitual diet on equol production by the gut microflora, Nutr Cancer, 36, 27, 10.1207/S15327914NC3601_5 Morton, 1994, Determination of lignans and isoflavonoids in human female plasma following dietary supplementation, J Endocrinol, 142, 251, 10.1677/joe.0.1420251 Adlercreutz, 1993, Quantitative determination of lignans and isoflavones in plasma of omnivorous and vegetarian women by isotope-dilution gas chromatography-mass spectrometry, Scand J Clin Lab Invest, 53, 5, 10.3109/00365519309090693 Adlercreutz, 1993, Plasma concentrations of phyto-oestrogens in Japanese men, Lancet, 342, 1209, 10.1016/0140-6736(93)92188-Y Nesbitt, 1999, Human metabolism of mammalian lignan precursors in raw and processed flaxseed, Am J Clin Nutr, 69, 549, 10.1093/ajcn/69.3.549 Lampe, 1994, Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder, Am J Clin Nutr, 60, 122, 10.1093/ajcn/60.1.122 Cunnane, 1995, Nutritional attributes of traditional flaxseed in healthy young adults, Am J Clin Nutr, 61, 62, 10.1093/ajcn/61.1.62 Rickard, 1996, Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed, J Nutr, 126, 2012 Setchell, 1998, Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones, Am J Clin Nutr, 68, 1333S, 10.1093/ajcn/68.6.1333S Tham, 1998, Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence, J Clin Endocrinol Metab, 83, 2223, 10.1210/jc.83.7.2223 Markiewicz, 1993, In vitro bioassays of non-steroidal phytoestrogens, J Steroid Biochem Mol Biol, 45, 399, 10.1016/0960-0760(93)90009-L Kuiper, 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptorβ, Endocrinology, 139, 4252, 10.1210/en.139.10.4252 Taylor, 2000, Immunolocalisation of oestrogen receptor beta (ERβ) in human tissues, J Mol Endocrinol, 24, 145, 10.1677/jme.0.0240145 Hirano, 1990, Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1, Cancer Invest, 8, 595, 10.3109/07357909009018926 Serraino, 1992, The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis, Nutr Cancer, 17, 153, 10.1080/01635589209514182 Peterson, 1992, Isoflavones inhibit the growth of human prostate cancer cells in culture, Proc Am Assoc Cancer Res, 33, 57 Yanajihara, 1993, Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract, Cancer Res, 53, 5815 Zava, 1997, Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro, Nutr Cancer, 27, 31, 10.1080/01635589709514498 Wang, 1996, Molecular effects of genistein on estrogen receptor mediated pathways, Carcinogenesis, 17, 271, 10.1093/carcin/17.2.271 Fotsis, 1993, Genistein, a dietary-derived inhibitor of in vitro angiogenesis, Proc Natl Acad Sci U S A, 90, 2690, 10.1073/pnas.90.7.2690 Akiyama, 1987, Genistein, a specific inhibitor of tyrosine-specific protein kinases, J Biol Chem, 262, 5592, 10.1016/S0021-9258(18)45614-1 Linassier, 1990, Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity, Biochem Pharmacol, 39, 187, 10.1016/0006-2952(90)90664-7 Okura, 1988, Effect of genistein on topoisomerase activity and on the growth of [Val 12] Ha-ras-transformed NIH 3T3 cells, Biochem Biophys Res Commun, 157, 183, 10.1016/S0006-291X(88)80030-5 Markovits, 1989, Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II, Cancer Res, 49, 5111 Kim, 1998, Mechanisms of action of the soy isoflavone genistein: Emerging role for its effects via transforming growth factor β signaling pathways, Am J Clin Nutr, 68, 1418S, 10.1093/ajcn/68.6.1418S Wei, 1993, Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein, Nutr Cancer, 20, 1, 10.1080/01635589309514265 Wei, 1995, Antioxidant and antipromotional effects of the soybean isoflavone genistein, Proc Soc Exp Biol Med, 208, 124, 10.3181/00379727-208-43844 Record, 1995, The antioxidant activity of genistein in vitro, J Nutr Biochem, 6, 481, 10.1016/0955-2863(95)00076-C Kitts, 1999, Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metablites enterodiol and enterolactone, Mol Cell Biochem, 202, 91, 10.1023/A:1007022329660 Vedavanam, 1999, Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE), Phytother Res, 13, 601, 10.1002/(SICI)1099-1573(199911)13:7<601::AID-PTR550>3.0.CO;2-O Nakashima, 1991, Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses, Mol Pharmacol, 39, 475 Asahi, 1992, Thombin-induced human platelet aggregation is inhibited by protein tyrosine-kinase inhibitors, ST638 and genistein, FEBS Lett, 309, 10, 10.1016/0014-5793(92)80728-Y Rendu, 1992, Inhibition of platelet activation by tyrosine kinase inhibitors, Biochem Pharmacol, 44, 881, 10.1016/0006-2952(92)90119-4 McNicol, 1992, The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase, Prostaglandins Leukot Essent Fatty Acids, 48, 379, 10.1016/0952-3278(93)90118-G Shen, 1990, Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor, Methods Enzymol, 187, 446, 10.1016/0076-6879(90)87051-4 Krol, 1995, Inhibition of nitric oxide (NO) production in murine macrophages by flavones, Biochem Pharmacol, 50, 1031, 10.1016/0006-2952(95)00237-T Atluru, 1993, Inhibition of bovine mononuclear cell proliferation, interleukin-2 synthesis, protein-tyrosine kinase and leukotiene-B(4) production by a protein-tyrosine kinase inhibitor, genistein, Vet Immunol Immunopathol, 38, 113, 10.1016/0165-2427(93)90117-M Hirakata, 1997, Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells, Kidney Int, 51, 1028, 10.1038/ki.1997.144 Kato, 1999, Involvement of PDGF in pressure-induced mesangial cell proliferation through PKC and tyrosine kinase pathways, Am J Physiol, 277, F105 Ha, 1998, Atherogenic lipoproteins enhance mesangial cell expression of platelet-derived growth factor: role of protein tyrosine kinase and cyclic AMP-dependent protein kinase, J Lab Clin Med, 131, 456, 10.1016/S0022-2143(98)90147-0 Yokoo, 1996, Dual regulation of IL-1β-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kB and AP-1, Am J Physiol, 270, F123 Coyne, 1990, Effect of tyrosine kinase inhibitor, genistein, on interleukin-1 stimulated PGE2 production in mesangial cells, Biochem Biophys Res Commun, 73, 718, 10.1016/S0006-291X(05)80094-4